MBX Biosciences Financials - Benzinga

SPY772.04+0.09%QQQ745.40+0.12%BTC/USD84,557.40+0.15%DIA517.72+0.04%GLD393.05−0.09%TLT79.38+0.08%

MBX Biosciences Inc

MBXNASDAQ

Trade with Public

Trade with Public

$53.63

-1.76-3.18%

At close: Sep 25, 5:00 PM EST

$53.63

N/A

After Hours: Sep 25, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

MBX Biosciences Financials

MBX Biosciences (MBX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
MBX Biosciences Q2 EPS $(0.78) Misses $(0.63) Estimate

MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.63) by 23.81 percent. This is a 34.48 percent decrease over losses of $(0.58) per share from

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

PRO
MBX Biosciences Q1 EPS $(0.51) Beats $(0.61) Estimate

MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.61) by 16.39 percent. This is a 28.17 percent increase over losses of $(0.71) per share from

Benzinga Newsdesk

PRO
MBX Biosciences Q4 EPS $(0.49) Beats $(0.68) Estimate

MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.68) by 27.84 percent. This is a 4.26 percent decrease over losses of $(0.47) per share from the

Benzinga Newsdesk

Earnings Scheduled For February 12, 2026

Benzinga Insights

Earnings Scheduled For December 18, 2025

Benzinga Insights